STAT+: Epic’s alleged anticompetitive practices under scrutiny from federal, state investigators
Reported by STAT News · all stories from statnews.com
Editorial digest
Epic Systems is reportedly under scrutiny from both federal and state investigators regarding its alleged anticompetitive business practices and the use of non-disclosure agreements.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom10/22/2026
STAT+: FDA finalizes its guidance on apps related to drugs, pharma rejoices
Federal regulators have completed formal guidelines for software applications paired with medications, drawing positive reactions from pharmaceutical manufacturers.
- Trusted health newsroom10/22/2026
STAT+: Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction
Virtual clinics are providing off-label GLP-1 therapies for substance use disorders before receiving formal regulatory authorization.
- Trusted health newsroom10/14/2026
STAT+: Lobbyists and trade groups fight to shape how states regulate medical AI
Industry representatives are working to influence state-level medical artificial intelligence rules.
- Trusted health newsroom10/15/2026
STAT+: ‘AI sandboxes’ are all the rage. Advocates scramble to control their future
Industry experts are working to influence the development of regulatory frameworks for artificial intelligence innovation zones.
- Trusted health newsroom10/6/2026
STAT+: FDA spells out 2027 AI guidance plans
The FDA has detailed its plans for AI guidelines in 2027.
- Trusted health newsroom10/7/2026
STAT+: Why health AI pilots in Utah may be on a collision course with the FDA
Utah's healthcare artificial intelligence trials may conflict with federal regulatory bodies.